10-Q Filing

TRANSMEDICS GROUP, INC. CIK: 1756262 Q2 2020

Filing Information

Form Type	10-Q
Accession Number	`0001564590-20-038399`
Period End Date	20200630
Filing Date	20200810
Fiscal Year	2020
Fiscal Period	Q2
XBRL Instance	tmdx-20200630.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 71 Income Statement 65 Cash Flow Statement 77 Stockholders Equity 44 Comprehensive Income 25

Balance Sheet 71 line items

Line Item	Tag	Value	Unit	Period
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, No Par Value	`PreferredStockNoParValue`	-	USD	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Preferred Stock, Shares Authorized	`PreferredStockSharesAuthorized`	25.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$51.15M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$47.24M	USD	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred Stock, Shares Issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.09M	USD	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$60.60M	USD	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred Stock, Shares Outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Marketable securities	`MarketableSecuritiesCurrent`	$88.22M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$4.43M	USD	Point-in-time
Accounts receivable	`AccountsReceivableNetCurrent`	$6.56M	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, No Par Value	`CommonStockNoParValue`	-	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Inventory	`InventoryNet`	$11.22M	USD	Point-in-time
Common Stock, Shares Authorized	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Inventory	`InventoryNet`	$12.55M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.54M	USD	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	27.14M	shares	Point-in-time
Common Stock, Shares, Issued	`CommonStockSharesIssued`	21.18M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$1.87M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	21.18M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$100.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$158.23M	USD	Point-in-time
Common Stock, Shares, Outstanding	`CommonStockSharesOutstanding`	27.14M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.40M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$4.79M	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashNoncurrent`	$500.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.00K	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$6.00K	USD	Point-in-time
Total assets	`Assets`	$163.14M	USD	Point-in-time
Total assets	`Assets`	$105.30M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$7.25M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$3.72M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$8.86M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesAndOtherLiabilities`	$8.33M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$1.02M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$166.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$370.00K	USD	Point-in-time
Current portion of deferred rent	`DeferredRentCreditCurrent`	$218.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$16.11M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$13.82M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$34.15M	USD	Point-in-time
Long-term debt, net of discount and current portion	`LongTermDebtNoncurrent`	$34.40M	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$389.00K	USD	Point-in-time
Deferred rent, net of current portion	`DeferredRentCreditNoncurrent`	$1.16M	USD	Point-in-time
Total liabilities	`Liabilities`	$50.65M	USD	Point-in-time
Total liabilities	`Liabilities`	$49.38M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, no par value; 25,000,000 shares authorized; no shares issued or outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 27,136,362 shares and 21,184,524 shares issued and outstanding at June 30, 2020 and December 28, 2019, respectively	`CommonStockValue`	$500.56M	USD	Point-in-time
Common stock, no par value; 150,000,000 shares authorized; 27,136,362 shares and 21,184,524 shares issued and outstanding at June 30, 2020 and December 28, 2019, respectively	`CommonStockValue`	$424.13M	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$36.00K	USD	Point-in-time
Accumulated other comprehensive income (loss)	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-2.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-386.83M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-369.48M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$71.16M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$54.65M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$46.68M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$-199.04M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$113.76M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$163.14M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$105.30M	USD	Point-in-time

Income Statement 65 line items

Line Item	Tag	Value	Unit	Period
Net revenue	`Revenues`	$10.92M	USD	2 Qtrs
Net revenue	`Revenues`	$10.34M	USD	2 Qtrs
Net revenue	`Revenues`	$5.67M	USD	1 Quarter
Net revenue	`Revenues`	$3.39M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$4.44M	USD	2 Qtrs
Cost of revenue	`CostOfRevenue`	$4.15M	USD	2 Qtrs
Cost of revenue	`CostOfRevenue`	$2.33M	USD	1 Quarter
Cost of revenue	`CostOfRevenue`	$1.48M	USD	1 Quarter
Gross profit	`GrossProfit`	$6.77M	USD	2 Qtrs
Gross profit	`GrossProfit`	$1.91M	USD	1 Quarter
Gross profit	`GrossProfit`	$3.33M	USD	1 Quarter
Gross profit	`GrossProfit`	$5.91M	USD	2 Qtrs
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$10.13M	USD	2 Qtrs
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$3.90M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$4.79M	USD	1 Quarter
Research, development and clinical trials	`ResearchAndDevelopmentExpense`	$8.67M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$6.25M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$5.87M	USD	1 Quarter
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$12.52M	USD	2 Qtrs
Selling, general and administrative	`SellingGeneralAndAdministrativeExpense`	$10.90M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$11.04M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$9.77M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$19.57M	USD	2 Qtrs
Total operating expenses	`OperatingExpenses`	$22.65M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-13.67M	USD	2 Qtrs
Loss from operations	`OperatingIncomeLoss`	$-7.71M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-7.86M	USD	1 Quarter
Loss from operations	`OperatingIncomeLoss`	$-15.88M	USD	2 Qtrs
Interest expense	`InterestExpense`	$2.21M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.11M	USD	1 Quarter
Interest expense	`InterestExpense`	$2.04M	USD	2 Qtrs
Interest expense	`InterestExpense`	$1.00M	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$614.00K	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$341.00K	USD	2 Qtrs
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$144.00K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$588.00K	USD	2 Qtrs
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$247.00K	USD	1 Quarter
Other income (expense), net	`OtherNonoperatingIncomeExpense`	$371.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-2.40M	USD	2 Qtrs
Total other expense, net	`NonoperatingIncomeExpense`	$-1.48M	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-630.00K	USD	1 Quarter
Total other expense, net	`NonoperatingIncomeExpense`	$-1.46M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-8.49M	USD	1 Quarter
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-16.07M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-17.33M	USD	2 Qtrs
Loss before income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$-9.19M	USD	1 Quarter
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$20.00K	USD	2 Qtrs
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$16.00K	USD	2 Qtrs
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$10.00K	USD	1 Quarter
Provision for income taxes	`CurrentIncomeTaxExpenseBenefit`	$6.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-17.35M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.09M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.50M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.70	USD	1 Quarter
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-2.21	USD	2 Qtrs
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.78	USD	2 Qtrs
Net loss per share attributable to common stockholders, basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.36	USD	1 Quarter
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	23.33M	shares	1 Quarter
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	7.28M	shares	2 Qtrs
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	22.26M	shares	2 Qtrs
Weighted average common shares outstanding, basic and diluted	`WeightedAverageNumberOfShareOutstandingBasicAndDiluted`	13.13M	shares	1 Quarter

Cash Flow Statement 77 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-33.50M	USD	Annual
Net loss	`ProfitLoss`	$-17.35M	USD	2 Qtrs
Net loss	`ProfitLoss`	$-16.09M	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$745.00K	USD	2 Qtrs
Depreciation and amortization expense	`DepreciationDepletionAndAmortization`	$534.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$277.00K	USD	2 Qtrs
Stock-based compensation expense	`ShareBasedCompensation`	$1.02M	USD	2 Qtrs
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$614.00K	USD	1 Quarter
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	$341.00K	USD	2 Qtrs
Change in fair value of preferred stock warrant liability	`FairValueAdjustmentOfWarrants`	-	USD	1 Quarter
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$249.00K	USD	2 Qtrs
Non-cash interest expense and end of term accretion expense	`NonCashInterestAndEndOfTermAccretionExpense`	$231.00K	USD	2 Qtrs
Net amortization (accretion) of premiums (discounts) on marketable securities	`AmortizationOfDebtDiscountPremium`	$-24.00K	USD	2 Qtrs
Net amortization (accretion) of premiums (discounts) on marketable securities	`AmortizationOfDebtDiscountPremium`	$49.00K	USD	2 Qtrs
Unrealized foreign currency transaction losses	`ForeignCurrencyTransactionGainLossUnrealized`	$131.00K	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-2.13M	USD	2 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$3.68M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$1.41M	USD	2 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$3.23M	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-259.00K	USD	2 Qtrs
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$324.00K	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-3.83M	USD	2 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$1.44M	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$660.00K	USD	2 Qtrs
Accrued expenses and other current liabilities	`IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities`	$816.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$848.00K	USD	2 Qtrs
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-130.00K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$174.00K	USD	2 Qtrs
Deferred rent	`IncreaseDecreaseInDeferredCharges`	$-623.00K	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-19.43M	USD	2 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-16.71M	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$397.00K	USD	2 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$151.00K	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$63.64M	USD	2 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$48.95M	USD	2 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$36.02M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-49.10M	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-28.01M	USD	2 Qtrs
Payments of public offering costs and other financing costs	`PaymentsOfStockIssuanceCosts`	$339.00K	USD	2 Qtrs
Payments of public offering costs and other financing costs	`PaymentsOfStockIssuanceCosts`	$1.98M	USD	2 Qtrs
Proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions`	$75.67M	USD	2 Qtrs
Proceeds from issuance of common stock in public offering, net of underwriting discounts and commissions	`ProceedsFromIssuanceOfCommonStockInInitialPublicOfferingNetOfUnderwritingDiscountsAndCommissions`	$97.37M	USD	2 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$10.00K	USD	2 Qtrs
Proceeds from issuance of common stock upon exercise of stock options	`ProceedsFromStockOptionsExercised`	$167.00K	USD	2 Qtrs
Proceeds from issuance of common stock in connection with employee stock purchase plan	`ProceedsFromStockPlans`	$197.00K	USD	2 Qtrs
Proceeds from Paycheck Protection Program loan	`ProceedsFromPaycheckProtectionProgramLoan`	$2.25M	USD	2 Qtrs
Repayment of Paycheck Protection Program loan	`RepaymentOfPaycheckProtectionProgramLoan`	$2.25M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$75.69M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$95.40M	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$125.00K	USD	2 Qtrs
Effect of exchange rate changes on cash, cash equivalents and restricted cash	`EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$89.00K	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$31.06M	USD	2 Qtrs
Net increase in cash, cash equivalents and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$27.00M	USD	2 Qtrs
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$51.65M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$51.65M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.74M	USD	Point-in-time
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$1.26M	USD	2 Qtrs
Transfers of inventory to property and equipment	`InventoryTransferToPropertyPlantAndEquipment`	$78.00K	USD	2 Qtrs
Reclassification of warrants to additional paid-in capital	`ReclassificationOfWarrantsToAdditionalPaidInCapital`	$-1.24M	USD	2 Qtrs
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$47.00K	USD	2 Qtrs
Purchases of property and equipment included in accounts payable	`CapitalExpendituresIncurredButNotYetPaid`	$19.00K	USD	2 Qtrs
Offering costs included in accounts payable and accrued expenses	`DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses`	$409.00K	USD	2 Qtrs
Offering costs included in accounts payable and accrued expenses	`DeferredOfferingCostsIncludedInAccountsPayableAndAccruedExpenses`	$1.38M	USD	2 Qtrs
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$51.15M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$47.24M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$20.09M	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Restricted cash	`RestrictedCashAndCashEquivalents`	$500.00K	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.74M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$51.65M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$20.59M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$47.74M	USD	Point-in-time

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Discounts and issuance costs of stock issued	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$628.00K	USD	1 Quarter
Discounts and issuance costs of stock issued	`AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts`	$5.97M	USD	1 Quarter
Balance	`StockholdersEquity`	$71.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$46.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$-199.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$113.76M	USD	Point-in-time
Conversion of convertible preferred stock into common stock upon initial public offering	`StockIssuedDuringPeriodValueConversionOfUnits`	$186.52M	USD	1 Quarter
Conversion of preferred stock warrants into common stock warrants upon initial public offering	`ConversionOfPreferredStockWarrantsIntoCommonStockWarrantsUponInitialPublicOffering`	$1.24M	USD	1 Quarter
Issuance of common stock in initial public offering,net of discounts and issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$91.40M	USD	1 Quarter
Issuance of common stock in initial public offering,net of discounts and issuance costs	`StockIssuedDuringPeriodValueNewIssues`	$75.04M	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$92.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$75.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$6.00K	USD	1 Quarter
Issuance of common stock upon the exercise of common stock options	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.00K	USD	1 Quarter
Issuance of common stock in connection with employee stock purchase plan	`StockIssuedDuringPeriodValueEmployeeStockPurchasePlan`	$197.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$57.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$631.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$220.00K	USD	1 Quarter
Stock-based compensation expense	`AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition`	$385.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-26.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-21.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$34.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$13.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-42.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-149.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$64.00K	USD	2 Qtrs
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$213.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-17.35M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.09M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.50M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Balance	`StockholdersEquity`	$71.16M	USD	Point-in-time
Balance	`StockholdersEquity`	$54.65M	USD	Point-in-time
Balance	`StockholdersEquity`	$-192.24M	USD	Point-in-time
Balance	`StockholdersEquity`	$46.68M	USD	Point-in-time
Balance	`StockholdersEquity`	$-199.04M	USD	Point-in-time
Balance	`StockholdersEquity`	$113.76M	USD	Point-in-time

Comprehensive Income 25 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-17.35M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.85M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-16.09M	USD	2 Qtrs
Net loss	`NetIncomeLoss`	$-8.50M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-9.20M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-6.89M	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-26.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-21.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$34.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$13.00K	USD	2 Qtrs
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$16.00K	USD	1 Quarter
Foreign currency translation adjustment	`OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax`	$-42.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-149.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$64.00K	USD	2 Qtrs
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$213.00K	USD	1 Quarter
Unrealized gains (losses) on marketable securities, net of tax of $0	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$30.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-191.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$38.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$43.00K	USD	2 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$9.00K	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-9.19M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-8.69M	USD	1 Quarter
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-17.31M	USD	2 Qtrs
Comprehensive loss	`ComprehensiveIncomeNetOfTax`	$-16.05M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.